logo
Plus   Neg
Share
Email

Eli Lilly Issues Updates On Insulin Supply - Quick Facts

Eli Lilly and Company (LLY) said the company does not currently anticipate shortages for any of its medicines, including all forms of insulin. The company said its insulin manufacturing sites in the U.S. and Europe remain operational. Eli Lilly noted that U.S. pharmacies that temporarily don't have Lilly medicines in stock due to higher demand can order them from wholesalers, and can be delivered in 1 to 2 days.

"COVID-19 is an unprecedented challenge for all of us, but Lilly has planned for such events. Our manufacturing facilities, supply chain, and Lilly Diabetes Solution Center are designed to support those who rely on insulin," said Mike Mason, president, Lilly Diabetes.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
Follow RTT